Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders
pa-20-185: nih research project grant (parent r01 clinical trial not allowed)pa-20-183: nih research project grant (parent r01 clinical trial required)pa-20-184: research project grant (parent r01 basic experimental studies with humans required)pa-20-200: nih small research grant program (parent r03 clinical trial not allowed)pa-20-196: nih exploratory/developmental research grant program (parent r21 basic experimental studies with humans required)pa-20-195: nih exploratory/developmental research grant program (parent r21 clinical trial not allowed)pa-20-194: nih exploratory/developmental research grant program (parent r21 clinical trial required)pa-18-775: pilot and feasibility studies in preparation for drug and alcohol abuse prevention trials (r34 clinical trial optional) or any re-issuancesnational institute on drug abuse (nida)the purpose of this notice is to encourage the submission of research project grant applications that address co-morbid substance use and/or substance use disorders, and other psychiatric disorders. research in response to this nosi may include etiologic investigations to inform prevention intervention, intervention development and testing, and research to address service delivery strategies to address co-morbid conditions. the intent is to encourage a broad portfolio of research, that enhances understanding of risk, etiology, prevention, treatment and service delivery related to co-occurring conditions.background:the association between substance use, substance use disorders, and psychiatric disorders, including depression, anxiety, bipolar disorder, adhd and other externalizing disorders, has been well established through population based epidemiologic surveys. numerous developmentally focused theory-based approaches have been proposed, including shared underlying vulnerabilities or risk factors. from a disorder perspective, prevalence can be expressed as either the prevalence of other psychiatric disorders among substance using populations or the prevalence of substance use among individuals with other psychiatric disorders, leading to variability in rates. mental illness is often characterized as a risk factor for substance use initiation and for transition from use to misuse and disorder, though the exact sequence and relationship between substance use, substance use disorders and psychiatric co-morbidity is unclear and may vary by disorder. for some substances and disorders, it may be the substance use that precedes the onset of other psychiatric symptoms. additional research is needed to determine the various trajectories of substance use and psychiatric symptoms, as well as strategies for intervention to change trajectories.research objectives:nida is interested in research project grant applications that would further our understanding of co-morbidity through studies that test etiological theories and interventions (treatment and prevention), across the lifespan.nida interest includes, but is not limited to, applications in the following areas:application and submission informationthis notice applies to due dates on or after october 05, 2020 and subsequent receipt dates through may 8, 2023submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcement through the expiration date of this notice.all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:scientific/research contact(s) amy b. goldstein, phdnational institute on drug abuse (nida) telephone: 301-827-4124 email: amy.goldstein@nih.gov weekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.